No Data
No Data
Express News | Guangzhou Kingmed Diagnostics Says Board Elects Liang Yaoming as Chairman
Why Guangzhou Kingmed Diagnostics Group's (SHSE:603882) Soft Earnings Are Just The Beginning Of Its Problems
Guangzhou Jinyu Medical Testing Group Co., Ltd. 2024 Semi-Annual Report
Summary of the 2024 semi-annual report of Guangzhou Jinyu Medical Testing Group Co., Ltd.
Guangzhou Kingmed Diagnostics Group (603882.SH) released its semi-annual performance with a net income of 89.65 million yuan, a 68.53% year-on-year decrease.
Guangzhou Kingmed Diagnostics Group (603882.SH) disclosed its semi-annual report for 2024, and during the reporting period, the company achieved revenue of 38.8 million...
Guangzhou Kingmed Diagnostics Group (603882.SH): net income in the first half of the year was approximately 89.65 million yuan, a year-on-year decrease of 68.53%.
On August 30th, Guoyuan Medicine (603882.SH) announced that the revenue for the first half of 2024 was approximately 3.881 billion yuan, a decrease of 9.92% year-on-year; the net income attributable to shareholders of the listed company was approximately 89.65 million yuan, a decrease of 68.53% year-on-year; and the basic earnings per share was 0.19 yuan.
No Data
No Data